Prescription pricing databases should include more details to assess prescribing rationalityBMJ 2001; 322 doi: http://dx.doi.org/10.1136/bmj.322.7279.173 (Published 20 January 2001) Cite this as: BMJ 2001;322:173
- Hugh McGavock, visiting professor (prescribing science), University of Ulster
- 55 Culcrum Road, Cloughmills, County Antrim BT44 9NJ
EDITOR—Campbell et al's study on prescribing indicators for general practices in the United Kingdom showed how difficult it is to conduct quality assurance of prescribing by using the existing prescription pricing databases in the United Kingdom.1 The authors selected 41 proxies of rational prescribing from prescribing analysis and cost (PACT) data, the English system. Only seven of these were rated as valid for economic rationality (cost) and five for scientific rationality (quality). …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial